Reduction and Return of Infectious Trachoma in Severely Affected Communities in Ethiopia
Overview
Tropical Medicine
Authors
Affiliations
Background: Antibiotics are a major tool in the WHO's trachoma control program. Even a single mass distribution reduces the prevalence of the ocular chlamydia that causes trachoma. Unfortunately, infection returns after a single treatment, at least in severely affected areas. Here, we test whether additional scheduled treatments further reduce infection, and whether infection returns after distributions are discontinued.
Methods: Sixteen communities in Ethiopia were randomly selected. Ocular chlamydial infection in 1- to 5-year-old children was monitored over four biannual azithromycin distributions and for 24 months after the last treatment.
Findings: The average prevalence of infection in 1- to 5-year-old children was reduced from 63.5% pre-treatment to 11.5% six months after the first distribution (P<0.0001). It further decreased to 2.6% six months after the fourth and final treatment (P = 0.0004). In the next 18 months, infection returned to 25.2%, a significant increase from six months after the last treatment (P = 0.008), but still far lower than baseline (P<0.0001). Although the prevalence of infection in any particular village fluctuated, the mean prevalence of the 16 villages steadily decreased with each treatment and steadily returned after treatments were discontinued.
Conclusion: In some of the most severely affected communities ever studied, we demonstrate that repeated mass oral azithromycin distributions progressively reduce ocular chlamydial infection in a community, as long as these distributions are given frequently enough and at a high enough coverage. However, infection returns into the communities after the last treatment. Sustainable changes or complete local elimination of infection will be necessary.
Trial Registration: ClinicalTrials.gov NCT00221364.
Last A, Shafi Abdurahman O, Greenland K, Robinson A, Collin C, Czerniewska A BMJ Open. 2024; 14(12):e084478.
PMID: 39719287 PMC: 11751794. DOI: 10.1136/bmjopen-2024-084478.
Comparison of metrics for assessing face washing behaviour for trachoma control.
Greenland K, Collin C, Etu E, Guye M, Hika D, Macleod D PLoS Negl Trop Dis. 2024; 18(8):e0012399.
PMID: 39141680 PMC: 11346966. DOI: 10.1371/journal.pntd.0012399.
Eliminating Trachoma in Africa: The Importance of Environmental Interventions.
Ageed A, Khan M Cureus. 2024; 16(1):e52358.
PMID: 38234389 PMC: 10792353. DOI: 10.7759/cureus.52358.
Trachoma risk factors in Oromia Region, Ethiopia.
Shafi Abdurahman O, Last A, Macleod D, Habtamu E, Versteeg B, Dumessa G PLoS Negl Trop Dis. 2023; 17(11):e0011679.
PMID: 37934731 PMC: 10629622. DOI: 10.1371/journal.pntd.0011679.
Goodhew E, Taoaba R, Harding-Esch E, Gwyn S, Bakhtiari A, Butcher R PLoS Negl Trop Dis. 2023; 17(7):e0011441.
PMID: 37418501 PMC: 10355439. DOI: 10.1371/journal.pntd.0011441.